Annual Short Term Debt
N/A
December 31, 2024
Summary
- TCRX annual short term debt is not available.
Performance
TCRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
$4.57 M
+$672.00 K+17.24%
December 31, 2024
Summary
- As of March 8, 2025, TCRX quarterly short term debt is $4.57 million, with the most recent change of +$672.00 thousand (+17.24%) on December 31, 2024.
- Over the past year, TCRX quarterly short term debt has dropped by -$2.02 million (-30.68%).
- TCRX quarterly short term debt is now -67.24% below its all-time high of $13.95 million, reached on June 30, 2024.
Performance
TCRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
TCRX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -30.7% |
| 3 y3 years | - | -16.7% |
| 5 y5 years | - | -16.7% |
TCRX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.2% | +176.8% | ||
| 5 y | 5-year | -67.2% | +223.0% | ||
| alltime | all time | -67.2% | +223.0% |
TScan Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $4.57 M(+17.2%) |
| Sep 2024 | - | $3.90 M(-72.1%) |
| Jun 2024 | - | $13.95 M(+37.6%) |
| Mar 2024 | - | $10.13 M(+53.7%) |
| Dec 2023 | $6.59 M(+79.1%) | $6.59 M(+20.2%) |
| Sep 2023 | - | $5.49 M(+30.3%) |
| Jun 2023 | - | $4.21 M(+9.7%) |
| Mar 2023 | - | $3.84 M(+4.2%) |
| Dec 2022 | $3.68 M | $3.68 M(+105.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.79 M(+2.8%) |
| Jun 2022 | - | $1.75 M(+2.8%) |
| Mar 2022 | - | $1.70 M(+2.8%) |
| Dec 2021 | $1.65 M(+16.7%) | $1.65 M(+1.9%) |
| Sep 2021 | - | $1.62 M(+2.9%) |
| Jun 2021 | - | $1.57 M(+2.9%) |
| Mar 2021 | - | $1.53 M(+8.1%) |
| Dec 2020 | $1.42 M(+219.4%) | - |
| Dec 2020 | - | $1.42 M |
| Dec 2019 | $443.00 K | - |
FAQ
- What is the all time high annual short term debt for TScan Therapeutics?
- What is TScan Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for TScan Therapeutics?
- What is TScan Therapeutics quarterly short term debt year-on-year change?
What is the all time high annual short term debt for TScan Therapeutics?
TScan Therapeutics all-time high annual short term debt is $6.59 M
What is TScan Therapeutics quarterly short term debt?
The current quarterly short term debt of TCRX is $4.57 M
What is the all time high quarterly short term debt for TScan Therapeutics?
TScan Therapeutics all-time high quarterly short term debt is $13.95 M
What is TScan Therapeutics quarterly short term debt year-on-year change?
Over the past year, TCRX quarterly short term debt has changed by -$2.02 M (-30.68%)